{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:05:10Z","timestamp":1789380310934,"version":"build-2803163510"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CAD"],"published-print":{"date-parts":[[2026,9,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Lenalidomide is an immunomodulatory drug. Its repurposing for refractory\nBehcet\u2019s Disease is a promising strategy. Behcet\u2019s Disease is a rare and complex autoinflammatory\ncondition. Current treatment options are limited. This study explored the drug\u2019s\ntherapeutic potential using clinical and computational analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study included a systematic review of clinical case reports. Computational methods\nincluded toxicological predictions, network pharmacology to screen common targets of lenalidomide\nand Behcet\u2019s Disease, and the construction of protein-protein interaction networks\nutilizing tools such as ProTox-3.0, ADMETlab 3.0, and Cytoscape. Additionally, molecular\ndocking (AutoDock Vina) and molecular dynamics simulations (GROMACS) were used to assess\nbinding and stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Clinical data showed low-dose lenalidomide provided rapid symptom relief and appeared\nto be well tolerated. Computational toxicology revealed a complex, dose-dependent safety\nprofile. Network analysis identified 63 common targets. Seven core genes were found, including\nIL6, TNF, and JAK1. These genes were enriched in immune pathways, particularly the\nJAK-STAT cascade. Molecular docking and dynamics confirmed stable binding to key targets\nlike IL6 and JAK1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Lenalidomide appears potentially effective in Behcet\u2019s Disease. Its action likely\ninvolves multi-target regulation of core immune pathways. Multi-target regulation of the JAKSTAT\nand TNF signaling cascades directly addresses the core autoinflammatory pathology of\nBehcet's Disease. The concordance between clinical efficacy and computational findings highlights\nits repurposing potential. The findings also stress the importance of dose optimization for\nsafety, generating a promising low-dose safety hypothesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>conclusion:<\/jats:title>\n                    <jats:p>Lenalidomide is a viable repurposed therapeutic candidate for refractory Beh\u00e7et\u2019s Disease. This old drug new use strategy offers a practical and mechanistically supported treatment avenue for this rare disease, demonstrating the value of computational and clinical integration in rare disease therapy development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Lenalidomide is a viable repurposing candidate warranting further clinical\ninvestigation for refractory Behcet\u2019s Disease. This strategy provides a mechanistically\nsupported treatment for this rare disease. Combining network pharmacology and molecular\ndynamics provides a robust preclinical rationale for repurposing lenalidomide in Behcet's\nDisease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0115734099491715260903114308","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:22:43Z","timestamp":1789377763000},"source":"Crossref","is-referenced-by-count":0,"title":["Repurposing Lenalidomide for Refractory Behcet\u2019s Disease: Systematic Review and Computational Pharmacology Insights for Rare Disease Therapy"],"prefix":"10.2174","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9222-7327","authenticated-orcid":true,"given":"Chengzhen","family":"Lyu","sequence":"first","affiliation":[{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-8423","authenticated-orcid":true,"given":"Shuai","family":"Li","sequence":"additional","affiliation":[{"name":"Gastroenterology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2265-7092","authenticated-orcid":true,"given":"Kun","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7579-0592","authenticated-orcid":true,"given":"Ziqi","family":"Guo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7605-0379","authenticated-orcid":true,"given":"Rou","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and PekingUnion Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0065-8219","authenticated-orcid":true,"given":"Wangyang","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1769-2480","authenticated-orcid":true,"given":"Weiyang","family":"Zheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-9874","authenticated-orcid":true,"given":"Dong","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China"},{"name":"Department of Gastroenterology, The People\u2019s Hospital of Xizang Autonomous Region, Lhasa, 850000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099491715260903114308","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258254\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734099491715260903114308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:22:45Z","timestamp":1789377765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258254\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734099491715260903114308","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}